Development of the India COVID-19 vaccine tracker

被引:1
|
作者
Singh, Harpreet [1 ]
Lohia, Rohan [6 ]
George, Leyanna Susan [2 ]
Gupta, Nivedita [3 ]
Thangaraj, Jeromie Winsley [15 ]
Rana, Salaj [1 ]
Rana, Shweta [1 ]
Kaur, Jasmine [1 ]
Shivam, Shashwat [6 ]
Arora, Narendra Kumar [14 ]
Muliyil, Jai Prakash [16 ]
Murhekar, Manoj, V [15 ]
Lodha, Rakesh [7 ]
Pandey, R. M. [8 ]
Rao, Vishnu Vardhan [9 ]
Dhandore, Suhas [10 ]
Malik, Akash [13 ]
Kumar, Vijay [11 ]
Tripathi, Ankit [12 ]
Panda, Samiran [4 ]
Bhargava, Balram [5 ]
机构
[1] All India Inst Med Sci, Div Biomed Informat, New Delhi, India
[2] All India Inst Med Sci, Clin Studies Trials & Project Unit, New Delhi, India
[3] All India Inst Med Sci, Virol Unit, New Delhi, India
[4] All India Inst Med Sci, Div Epidemiol & Communicable Dis, New Delhi, India
[5] All India Inst Med Sci, Indian Council Med Res, New Delhi, India
[6] All India Inst Med Sci, Clinton Hlth Access Initiat, India Off, New Delhi, India
[7] All India Inst Med Sci, Dept Paediat, New Delhi, India
[8] All India Inst Med Sci, Dept Biostat, New Delhi, India
[9] Minist Hlth & Family Welf, ICMR Natl Inst Med Stat, Delhi, India
[10] Minist Hlth & Family Welf, Div Immunizat, Delhi, India
[11] Minist Hlth & Family Welf, eHlth, Delhi, India
[12] Minist Hlth & Family Welf, Ctr Hlth Informat, Delhi, India
[13] United Nations Dev Programme, New Delhi, India
[14] INCLEN Trust Int, Delhi, India
[15] ICMR Natl Inst Epidemiol, Chennai, Tamil Nadu, India
[16] Christian Med Coll & Hosp, Dept Community Med, Vellore, Tamil Nadu, India
关键词
COVID-19; CoWIN; India; vaccine effectiveness; vaccine tracker;
D O I
10.4103/ijmr.ijmr_3500_21
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
COVID-19 was declared a pandemic by the World Health Organization (WHO) on March 11, 2020. Since then, efforts were initiated to develop safe and effective vaccines. Till date, 11 vaccines have been included in the WHO's emergency use list. The emergence and spread of variant strains of SARS-CoV-2 has altered the disease transmission dynamics, thus creating a need for continuously monitoring the real-world effectiveness of various vaccines and assessing their overall impact on disease control. To achieve this goal, the Indian Council of Medical Research (ICMR) along with the Ministry of Health and Family Welfare, Government of India, took the lead to develop the India COVID-19 Vaccination Tracker by synergizing three different public health databases: National COVID-19 testing database, CoWIN vaccination database and the COVID-19 India portal. A Vaccine Data Analytics Committee (VDAC) was constituted to advise on various modalities of the proposed tracker. The VDAC reviewed the data related to COVID-19 testing, vaccination and patient outcomes available in the three databases and selected relevant data points for inclusion in the tracker, following which databases were integrated, using common identifiers, wherever feasible. Multiple data filters were applied to retrieve information of all individuals >= 18 yr who died after the acquisition of COVID-19 infection with or without vaccination, irrespective of the time between vaccination and test positivity. Vaccine effectiveness (VE) against the reduction of mortality and hospitalizations was initially assessed. As compared to the hospitalization data, mortality reporting was found to be much better in terms of correctness and completeness. Therefore, hospitalization data were not considered for analysis and presentation in the vaccine tracker. The vaccine tracker thus depicts VE against mortality, calculated by a cohort approach using person-time analysis. Incidence of COVID-19 deaths among one- and two-dose vaccine recipients was compared with that among unvaccinated groups, to estimate the rate ratios (RRs). VE was estimated as 96.6 and 97.5 per cent, with one and two doses of the vaccines, respectively, during the period of reporting. The India COVID-19 Vaccination Tracker was officially launched on September 9, 2021. The high VE against mortality, as demonstrated by the tracker, has helped aid in allaying vaccine hesitancy, augmenting and maintaining the momentum of India's COVID-19 vaccination drive.
引用
收藏
页码:513 / 517
页数:4
相关论文
共 50 条
  • [31] The COVID-19 vaccine development: A pandemic paradigm
    Carneiro, Diego C.
    Sousa, Jessica D.
    Monteiro-Cunha, Joana P.
    [J]. VIRUS RESEARCH, 2021, 301
  • [32] COVID-19: Coronavirus Vaccine Development Updates
    Zhao, Jing
    Zhao, Shan
    Ou, Junxian
    Zhang, Jing
    Lan, Wendong
    Guan, Wenyi
    Wu, Xiaowei
    Yan, Yuqian
    Zhao, Wei
    Wu, Jianguo
    Chodosh, James
    Zhang, Qiwei
    [J]. FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [33] The Covid-19 Vaccine-Development Multiverse
    Heaton, Penny M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (07): : 682 - 682
  • [34] Vaccine Development Builds on COVID-19 Breakthroughs
    Wechsler, Jill
    [J]. BIOPHARM INTERNATIONAL, 2023, 36 (03) : 8 - 9
  • [35] COVID-19 Vaccine Development,Trials and Tribulations
    Sebastian, Juny
    Ravi, Mandyam Dhati
    Kumar, Tegginamat Pramod
    [J]. INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2020, 54 (03) : S457 - S463
  • [36] Progress and Concept for COVID-19 Vaccine Development
    Wu, Suh-Chin
    [J]. BIOTECHNOLOGY JOURNAL, 2020, 15 (06)
  • [37] The Covid-19 Vaccine-Development Multiverse
    Heaton, Penny M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (20): : 1986 - 1988
  • [38] Advances in COVID-19 mRNA vaccine development
    Fang, Enyue
    Liu, Xiaohui
    Li, Miao
    Zhang, Zelun
    Song, Lifang
    Zhu, Baiyu
    Wu, Xiaohong
    Liu, Jingjing
    Zhao, Danhua
    Li, Yuhua
    [J]. SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2022, 7 (01)
  • [39] VIROLOGY OF COVID-19, VACCINE DEVELOPMENT, AND EVOLUTION
    Quincer, Elizabeth
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2021, 60 (10): : S50 - S50
  • [40] COVID-19 Vaccine Development, Testing, and Distribution
    O'Malley, Patricia
    [J]. CLINICAL NURSE SPECIALIST, 2021, 35 (02) : 62 - 64